New building of Loxxess Pharma reaches to Austria

EUR 15 million investment by Loxxess Pharma in Neutraubling near Regensburg meets requirements of the EU Good Distribution Practice

Loxxess Pharma GmbH has opened a new logistics facility in Neutraubling close to Regensburg on 20 March. The investment totals about EUR 15 million. The entirely air conditioned group of buildings expands the available capacity for storage, throughput and fine order picking of finished pharmaceuticals, and increases the pharmaceutical drug safety.

On 22,000 m² the logistics center offers more than 18,000 pallet spaces in the air-conditioned high bay warehouse. An additional cold storage holds more than 1,500 pallets, a deep freeze warehouse holds around 100 pallets and a special hazardous goods store can hold an additional 250 pallets.

Through complete air conditioning, monitoring and documentation of factors such as temperature and humidity as well as other organisational measures the location meets the tightened requirements of the 2013 EU Good Distribution Practice (EU GDP). In addition, the company has a wholesale and manufacturers permission and is certified according to ISO 9001.

With the new location Loxxess Pharma responds to the increased demand for GDP-compliant storage of temperature-sensitive pharmaceuticals. The direct access to the A3 motorway simplifies the implementation of international logistics concepts.

Loxxess Pharma GmbH is a joint venture of Aenova Holding GmbH, Alloga S.à.r.l., Haupt Pharma Wolfrathausen GmbH and Loxxess AG. The group’s pan-European network has more than 1,600 employees in 15 countries.

In this group Loxxess Pharma operates direct distribution centre and professional pre-wholesales at three locations in Germany. These offer the best conditions and the highest quality for the storage and distribution of pharmaceuticals, medical products, food supplements and high-quality cosmetics and other sophisticated goods.

www.loxxess.de

Quelle: LogEastics
Portal: www.logistik-express.com